Tyche Industries Ltd.

BSE: 532384 SECTOR: Pharmaceuticals & Drugs  16k   238   21

135.35
+0.05 (0.04%)
BSE: Today, 05:10 PM

Price Summary

Today's High

₹ 139.9

Today's Low

₹ 133.15

52 Week High

₹ 228.5

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

138.73 Cr.

Enterprise Value

77.94 Cr.

No. of Shares

1.03 Cr.

P/E

14.87

P/B

1.33

Face Value

₹ 10

Div. Yield

1.11 %

Book Value (TTM)

₹  101.68

CASH

60.79 Cr.

DEBT

0 Cr.

Promoter Holding

61.97 %

EPS (TTM)

₹  9.1

Sales Growth

6.16%

ROE

23.08 %

ROCE

30.89%

Profit Growth

13.81 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6.16%
3 Year14.89%
5 Year7.67%

Profit Growth

1 Year13.81%
3 Year50.5%
5 Year51.96%

ROE%

1 Year23.08%
3 Year20.41%
5 Year15.89%

ROCE %

1 Year30.89%
3 Year27.4%
5 Year22.25%

Debt/Equity

0

Price to Cash Flow

8.96

Interest Cover Ratio

3579.5881030144

CFO/PAT (5 Yr. Avg.)

0.948119806082368

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2022 61.97 0
Mar 2022 61.97 0
Dec 2021 61.97 0
Sep 2021 61.97 0
Jun 2021 61.97 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 50.496519976533% for the Past 3 years.
  • Company has been maintaining healthy ROE of 20.4139824190908% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.3955897931528% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 3579.5881030144.
  • The Company has been maintaining an effective average operating margins of 21.6036315390581% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 22.8902653393061 days.
  • Company has a healthy liquidity position with current ratio of 5.41377440642126.
  • The company has a high promoter holding of 61.97%.

 Limitations

  • The company has shown a poor revenue growth of 14.8876367879194% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net Sales 16.02 12.39 19.05 14.57 16.27
Total Expenditure 13.9 10.44 13.8 13.12 13.95
Operating Profit 2.11 1.95 5.25 1.45 2.31
Other Income 1 0.82 0.92 1.22 1.2
Interest 0 0 0 0 0
Depreciation 0.41 0.45 0.45 0.47 0.42
Exceptional Items -0.99 0 0 0.06 0
Profit Before Tax 1.7 2.31 5.72 2.27 3.09
Tax 0.57 0.58 1.47 0.46 0.8
Profit After Tax 1.14 1.73 4.25 1.81 2.29
Adjusted EPS (Rs) 1.11 1.69 4.15 1.77 2.24

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 42.61 51.6 53.95 73.7 78.24
Total Expenditure 36.61 42.57 44.78 52.31 53.53
Operating Profit 6 9.03 9.17 21.39 24.71
Other Income 1.89 1.69 2.52 3.68 4.74
Interest 0.08 0.01 0 0 0.01
Depreciation 1.87 1.85 1.84 1.74 1.72
Exceptional Items 0 0 0 0 -0.99
Profit Before Tax 5.93 8.86 9.85 23.33 26.73
Tax 2.85 3 2.7 5.77 6.75
Net Profit 3.08 5.86 7.15 17.56 19.98
Adjusted EPS (Rs.) 3.01 5.72 6.97 17.14 19.51

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 10.23 10.25 10.25 10.25 10.25
Total Reserves 37.66 42.88 50.02 66.93 85.72
Borrowings 0 0 0 0 0
Other N/C liabilities 3.1 3.39 3.15 2.89 3.2
Current liabilities 10.01 10.21 10.6 14.63 17.79
Total Liabilities 60.99 66.72 74.01 94.69 116.95
Assets
Net Block 26.57 19.84 19.15 17.67 17.93
Capital WIP 0.33 0 0 0 0.53
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 1.82 0.76 0.78 0.72 0.78
Other N/C Assets 0.23 1.5 1.39 1.39 1.39
Current Assets 32.03 44.62 52.69 74.92 96.32
Total Assets 60.99 66.72 74.01 94.69 116.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 5.93 8.86 9.85 23.33 26.53
Adjustment -0.91 -2.38 -2.92 -6.67 -7.89
Changes in Assets & Liabilities 6.35 -1.45 -3.18 -1.45 -3.16
Tax Paid 0 0 0 0 0
Operating Cash Flow 11.37 5.04 3.75 15.21 15.48
Investing Cash Flow 0.6 6.29 0.63 2.04 0.41
Financing Cash Flow -10.59 -0.6 -0.07 -0.62 -1.02
Net Cash Flow 1.38 10.72 4.31 16.63 14.86

Corporate Actions

Investors Details

PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Promoters 61.97 61.97 61.97 61.97 61.97
silver oak technol... 19.31 19.31 19.31 19.31 19.31
sri indra distille... 18.43 18.43 18.43 18.43 18.43
g ganesh kumar - 13.74 13.74 13.74 13.74
g.ganesh kumar 13.74 - - - -
sandeep gokaraju 8.22 8.22 8.22 8.22 8.22
innag projects pri... 1.82 1.82 1.82 1.82 1.82
siri cellars priva... 0.30 0.30 0.30 0.30 0.30
siri cellars priva... - - - - -
satya srinivas upp... - - - 0.13 0.13
uppalapati satya s... 0.13 0.13 0.13 - -
vijaya kumari goka... 0.02 0.02 0.02 0.02 0.02
PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Investors 38.03 38.03 38.03 38.03 38.03
plutus techlabs li... 6.40 6.40 6.40 - -
plutus techlabs pr... - - - 6.40 6.40
iepf 1.60 1.60 1.68 1.66 1.66
lincoln p coelho 1.46 1.46 1.46 1.46 1.46

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Tyche Inds Stock Price Analysis and Quick Research Report. Is Tyche Inds an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Tyche Inds and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 15.4779615 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Tyche Inds has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Tyche Inds , the EPS growth was 13.8077452853182 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Tyche Inds has OPM of 31.5871099872718 % which is a good sign for profitability.
     
  • ROE: Tyche Inds have a healthy ROE of 23.0845619907701 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Tyche Inds

X